850 filings
Page 2 of 43
4
4futsjgx 8rj
18 Aug 20
NAVIDEA BIOPHARMACEUTICALS / Jed Latkin ownership change
9:13pm
8-K
j191tky
17 Aug 20
Entry into a Material Definitive Agreement
4:03pm
8-K
390fp6dd
13 Aug 20
Navidea Biopharmaceuticals Reports Second Quarter and Year-to-Date 2020 Financial Results
4:59pm
8-K
reviuyt
11 Aug 20
Navidea Biopharmaceuticals Signs Binding Framework for Commercialization Partnership with Jubilant Radiopharma
9:17pm
424B5
50b00fokimxg sel
11 Aug 20
Prospectus supplement for primary offering
5:28pm
8-K
fvfnimj nh0i3ceq
10 Aug 20
Other Events
7:42am
8-K
xv5vi6
31 Jul 20
Departure of Directors or Certain Officers
4:01pm
424B3
o1gzf2gkhdpqkq4fi89
24 Jun 20
Prospectus supplement
7:47am
EFFECT
gf1xo1k45zd
24 Jun 20
Notice of effectiveness
12:15am
CORRESP
2mo8f w65
22 Jun 20
Correspondence with SEC
12:00am
CORRESP
m9tka6l 49rfx3i
17 Jun 20
Correspondence with SEC
12:00am
UPLOAD
2uj3er
16 Jun 20
Letter from SEC
12:00am
4
lerif4i0 k6jl
4 Jun 20
NAVIDEA BIOPHARMACEUTICALS / Michael Stanley Rosol ownership change
4:18pm
4
039iee4
4 Jun 20
NAVIDEA BIOPHARMACEUTICALS / Jed Latkin ownership change
4:18pm
8-K
91rdnvu4z
4 Jun 20
Departure of Directors or Certain Officers
4:15pm